1. In this study we compared the 500 MHz H-1-NMRs from native and oxid
ized low-density lipoproteins. 2. The measurements revealed a characte
ristic pattern of three resonances in spectra from oxidized, but not f
rom native low-density liprotein at 1.17 p.p.m., 1.18 p.p.m. and 1.20
p.p.m. (relative to 3-trimethylsilyl-[2,2,3,3-H-2(4)]-propionate). 3.
A quantitative comparison between these resonances in sera from patien
ts with coronary heart disease and healthy control subjects revealed t
hat the intensity was significantly higher in patients with coronary h
eart disease (1.17 p.p.m.: 0.026 +/- 0.014 versus 0.015 +/- 0.019; 1.1
8 p.p.m.: 0.032 +/- 0.011 versus 0.017 +/- 0.021; 1.20 p.p.m.: 0.030 /- 0.066 versus 0.010 +/- 0.005; P < 0.05 compared with healthy contro
l subjects for each resonance). 4. Fractionation of sera from patients
with coronary heart disease revealed that the resonances equal to tho
se obtained from experimentally oxidized low-density lipoprotein are i
ndeed caused by the low-density lipoprotein fraction of the sera. 5. W
hen the NMRs from sera were calibrated with oxidized low-density lipop
rotein prepared by Cu2+ oxidation, a concentration of 66.5 +/- 28.6 mu
g/ml and 36.3 +/- 23.7 mu g/ml (P < 0.05) was estimated in patients w
ith coronary heart disease and healthy subjects respectively. Elevated
levels of oxidized low-density lipoprotein also occurred in those pat
ients with normal serum concentrations of total low-density lipoprotei
n. 6. The study shows a simple method to measure oxidized low-density
lipoprotein in human serum and may gain interest to assess the cardiov
ascular risk factor profiles more completely.